In the modern age, workers in Silicon Valley have made microdosing popular. They use it as a productivity edge in uber-competitive work environment.
A Brief History of Microdosing Mushrooms
Microdosing is not a new idea. The pharmaceutical industry uses microdosing to learn about a drug’s pharmacokinetics.
In the 1960s, psychologist and researcher James Fadiman was experimenting with using psychedelics as medicine. His research ended when recreational use of hallucinogens became popular and the government stopped funding the experiments.
At that time, the research on psilocybin was showing exciting promise in two areas: substance abuse and end-of-life anxiety and depression.
In the early 2000s, there was new interest in psilocybin, the active compound in “magic mushrooms,” as a medical treatment. The Food and Drug Administration (FDA) gave the study of psychedelic drugs “breakthrough status.” Dr. Fadiman and others could now resume research in psychedelics as medicine.
Since its early use in Silicon Valley, more people began microdosing mushrooms. Many consider it a productivity hack because it can increase focus, cognitive ability, and creativity.
In this article, we’ll talk about the history and science of microdosing mushrooms, its potential benefits and side effects, and how it can help people with chronic pain.
NOTE: At this time, the hallucinogen in magic mushrooms is a schedule I drug (meaning it has no accepted medical use). It is still illegal in most places. Our intent in writing this article is to inform our readers of research that may have future benefits for chronic pain sufferers.
What Is Microdosing, and How Can It Help Pain Patients?
Microdosing is the use of a tiny dose of a psychedelic substance (one-tenth of the usual “trip dose”) to improve cognitive abilities, concentration, or creativity without experiencing an altered level of consciousness.
In the case of magic mushrooms, the active compound is psilocybin, a hallucinogen produced by many types of fungi. While pain relief isn’t the most common reason people give for microdosing psilocybin, some say it helps with certain types of pain.
Another potential benefit for chronic pain sufferers is the treatment of pain-induced psychiatric symptoms. Psilocybin can elevate mood and reduce symptoms of anxiety and treatment-resistant depression. It may help to break the pain-depression-pain cycle that debilitates many chronic pain sufferers.
Microdosing for Mental Health Conditions
The effect of microdosing can be twofold for people with chronic pain. While it helps with long-term pain like cluster headaches, it also works as a psychedelic serotonin agonist (PSA). PSAs work on the neurologic pathways of the brain. They create new links that allow parts of the brain that don’t normally communicate, talk to each other and create new thoughts and experiences.
The effects of this reorganization can have long-term results. Full-dose studies found that psilocybin reduced symptoms of cancer-related anxiety (with one dose) and treatment-resistant depression (with two spaced doses) for six months and three months, respectively.
In all, seven clinical trials found that psilocybin use caused reductions in psychiatric rating scores or improved response and remission rates.
What’s more, psilocybin may be protective against suicidality.
Microdosing Mushrooms for Addiction
The studies mentioned above found psilocybin to also be a promising treatment for alcohol and tobacco addiction with increased abstinence rates and no severe adverse reactions.
The mechanism that makes psilocybin a potential treatment for anxiety and depression may work in the same way to reduce addictive behaviors.
In another study, most participants reported significantly decreased use of alcohol, caffeine, cannabis, illicit substances, and psychiatric medications.
Researchers concluded that psilocybin microdosing warrants more research on its potential to treat substance use disorders.
This could be great news for chronic pain sufferers who form addictions by self-medicating to decrease pain.
For a more in-depth look at the use of psilocybin to treat addiction disorders, see this article at Psychology Today.
Risks and Side Effects of Psilocybin
For all its potential benefits, psilocybin also carries risks. The most common side effects are headaches that are not severe or disabling and mood lability. Both are more likely to occur with higher doses, however.
Other reported side effects include dizziness, nausea, muscle weakness, numbness, and loss of appetite.
The Future of Mushroom Microdosing
As discussed above, in 2018, the Food and Drug Administration (FDA) approved a clinical trial of psilocybin as a treatment for depression. Since then, Johns Hopkins University has established a Center for Psychedelic and Consciousness Research.
For now, though, mushrooms are still illegal in the US, though three cities have decriminalized them: Denver, Colorado; Oakland, California; and Santa Cruz, California. The state of Oregon is working toward doing the same, but the coronavirus pandemic has slowed down their progress.
In the meantime, Johns Hopkins uses synthetic psilocybin in pill form in their clinical trials. A synthetic form of the drug would make therapeutic dosing accurate and predictable for use as a pharmaceutical.
Psilocybin is known to increase mood, concentration, creativity, and productivity, but research is still in the early stages. While we know that it helps with cluster headaches and phantom limb pain, researchers have only scratched the surface of its potential to treat pain.
Still, some researchers have found mushroom microdosing to be safe and non-addictive, and it may be an effective treatment for other conditions that can contribute to chronic pain, such as anxiety, depression, and substance abuse.
If you would like to know more about psilocybin microdosing research, visit the Multidisciplinary Association for Psychedelic Studies (MAPS) for a list of completed and ongoing clinical studies.
What topics should we cover about psychedelics for chronic illness?
Comment below or email us at firstname.lastname@example.org with your ideas!
Are you on Facebook?
Join our online community by clicking here.